Study Subject Participation Status | Multiple Sclerosis Clinical Trial Specified | Clinic Visits Completed
Item
must be a subject currently participating in study 205ms301 (nct01064401), or subject currently participating in study 205ms203 (nct01051349) or study 205ms302 (nct01462318) who has completed end of study visit (week 96 or later).
boolean
C2348568 (UMLS CUI [1])
C0026769 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0205369 (UMLS CUI [2,3])
C0008952 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
Childbearing Potential Contraceptive methods
Item
women of childbearing potential must practice effective contraception during the study and be willing and able to continue contraception for 4 months after their last dose of study treatment.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Study Subject Participation Status | Multiple Sclerosis Clinical Trial Specified | Therapeutic procedure Discontinued | Termination Clinic Visit
Item
any subject who permanently discontinued study treatment in study 205ms301 (nct01064401), study 205ms203 (nct01051349) or study 205ms302 (nct01462318) prior to the end of the study treatment period, or had an early termination visit in study 205ms301, study 205ms203 (nct01051349) or study 205ms302 (nct01462318).
boolean
C2348568 (UMLS CUI [1])
C0026769 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0205369 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C1692758 (UMLS CUI [4,1])
C0008952 (UMLS CUI [4,2])
Medical History Change Preventing Daclizumab HYP | Laboratory Procedures Study Subject Participation Status Excluded | Medical condition Study Subject Participation Status Excluded
Item
any significant change in the subject's medical history that would preclude administration of biib019, including laboratory tests or a current clinically significant condition that, in the opinion of the investigator, would have excluded the subject's participation in study 205ms301 (nct01064401), study 205ms203 (nct01051349) or study 205ms302 (nct01462318).
boolean
C0262926 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C4042011 (UMLS CUI [1,4])
C0022885 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
C3843040 (UMLS CUI [3,1])
C2348568 (UMLS CUI [3,2])
C0332196 (UMLS CUI [3,3])
Factor Preventing Clinical Trial Treatment
Item
the investigator must re review the subject's medical fitness for participation and consider any factors that would preclude treatment in this study 205ms303.
boolean
C1521761 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
Eligibility Criteria Study Protocol
Item
note: other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])